Edonerpic
Edonerpic Uses, Dosage, Side Effects, Food Interaction and all others data.
Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.
Trade Name | Edonerpic |
Generic | Edonerpic |
Edonerpic Other Names | Edonerpic |
Type | |
Formula | C16H21NO2S |
Weight | Average: 291.41 Monoisotopic: 291.129300094 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in alzheimer's disease.
How Edonerpic works
T-817MA has neuroprotective properties. Toyama Chemical has demonstrated that T-817MA prevents neurodegeneration induced by Amyloid-b protein. Accumulation of Amyloid-b protein is considered to be central to the pathogenesis of Alzheimer's disease. The neuroprotective properties of T-817MA were also observed in a mutant tau induced Alzheimer's disease model. Besides these neuroprotective properties, T-817MA also promotes neurite outgrowth.
Innovators Monograph
You find simplified version here Edonerpic